• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂质纳米粒药物释放的比较数学分析。

A Comparative Mathematical Analysis of Drug Release from Lipid-Based Nanoparticles.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shiraz University of Medical Science, Shiraz, Iran.

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

AAPS PharmSciTech. 2024 Sep 5;25(7):208. doi: 10.1208/s12249-024-02922-7.

DOI:10.1208/s12249-024-02922-7
PMID:39237678
Abstract

Mathematical modeling of drug release from drug delivery systems is crucial for understanding and optimizing formulations. This research provides a comparative mathematical analysis of drug release from lipid-based nanoparticles. Drug release profiles from various types of lipid nanoparticles, including liposomes, nanostructured lipid carriers (NLCs), solid lipid nanoparticles (SLNs), and nano/micro-emulsions (NEMs/MEMs), were extracted from the literature and used to assess the suitability of eight conventional mathematical release models. For each dataset, several metrics were calculated, including the coefficient of determination (R), adjusted R, the number of errors below certain thresholds (5%, 10%, 12%, and 20%), Akaike information criterion (AIC), regression sum square (RSS), regression mean square (RMS), residual sum of square (rSS), and residual mean square (rMS). The Korsmeyer-Peppas model ranked highest among the evaluated models, with the highest adjusted R values of 0.95 for NLCs and 0.93 for other liposomal drug delivery systems. The Weibull model ranked second, with adjusted R values of 0.92 for liposomal systems, 0.94 for SLNs, and 0.82 for NEMs/MEMs. Thus, these two models appear to be more effective in forecasting and characterizing the release of lipid nanoparticle drugs, potentially making them more suitable for upcoming research endeavors.

摘要

药物释放的数学建模对于理解和优化制剂至关重要。本研究对基于脂质的药物传递系统中的药物释放进行了比较性的数学分析。从文献中提取了各种类型的脂质纳米粒子(包括脂质体、纳米结构脂质载体(NLCs)、固体脂质纳米粒子(SLNs)和纳米/微乳液(NEMs/MEMs))的药物释放曲线,并利用这八种常规数学释放模型对其进行了评估。针对每个数据集,计算了多个指标,包括决定系数(R)、调整 R、低于特定阈值(5%、10%、12%和 20%)的误差数、赤池信息量准则(AIC)、回归平方和(RSS)、回归均方根(RMS)、残差平方和(rSS)和残差均方根(rMS)。在评估的模型中,Korsmeyer-Peppas 模型排名最高,其调整后的 R 值对 NLCs 为 0.95,对其他脂质体药物传递系统为 0.93。Weibull 模型排名第二,对脂质体系统的调整后的 R 值为 0.92,对 SLNs 为 0.94,对 NEMs/MEMs 为 0.82。因此,这两种模型似乎更有效地预测和描述了脂质纳米粒子药物的释放,这可能使它们更适合未来的研究工作。

相似文献

1
A Comparative Mathematical Analysis of Drug Release from Lipid-Based Nanoparticles.脂质纳米粒药物释放的比较数学分析。
AAPS PharmSciTech. 2024 Sep 5;25(7):208. doi: 10.1208/s12249-024-02922-7.
2
Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.长春新碱和替莫唑胺联合化疗治疗脑胶质瘤:比较固体脂质纳米粒和纳米结构脂质载体双重药物递送。
Drug Deliv. 2016 Oct;23(8):2720-2725. doi: 10.3109/10717544.2015.1058434. Epub 2015 Jul 23.
3
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?载克霉唑固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)的制备、表征及比较评价:NLCs 是否优于 SLNs?
Eur J Pharm Sci. 2012 Aug 30;47(1):139-51. doi: 10.1016/j.ejps.2012.05.010. Epub 2012 Jun 1.
4
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.蔗糖酯稳定的固体脂质纳米粒和纳米结构脂质载体。二、负载咪康唑抗真菌药物的纳米粒子分散体及其凝胶制剂的评价。
Nanotechnology. 2014 Mar 14;25(10):105102. doi: 10.1088/0957-4484/25/10/105102. Epub 2014 Feb 14.
5
Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?纳米结构脂质载体、固体脂质纳米粒和聚合物纳米粒:哪种药物递送系统对胶质母细胞瘤化疗效果更佳?
Drug Deliv. 2016 Nov;23(9):3408-3416. doi: 10.1080/10717544.2016.1189465. Epub 2016 Jun 8.
6
Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.蔗糖酯稳定的固体脂质纳米粒和纳米结构脂质载体。I. 制剂变量对克霉唑负载纳米粒的理化性质、药物释放和稳定性的影响。
Nanotechnology. 2014 Mar 14;25(10):105101. doi: 10.1088/0957-4484/25/10/105101. Epub 2014 Feb 14.
7
Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.固体脂质纳米粒和纳米结构脂质载体:制备方法和给药途径的综述。
Pharm Dev Technol. 2022 Jun;27(5):525-544. doi: 10.1080/10837450.2022.2084554. Epub 2022 Jul 14.
8
Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.米诺地尔纳米结构脂质载体的制备与表征
AAPS PharmSciTech. 2017 Feb;18(2):509-516. doi: 10.1208/s12249-016-0519-x. Epub 2016 Apr 27.
9
Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.固体脂质纳米粒作为药物传递系统的观点和展望。
Molecules. 2022 Feb 24;27(5):1543. doi: 10.3390/molecules27051543.
10
QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.采用多变量统计技术对奥美沙坦酯纳米结构脂质载体(NLCs)进行质量源于设计(QbD)驱动的开发与评价。
Drug Dev Ind Pharm. 2018 Mar;44(3):407-420. doi: 10.1080/03639045.2017.1395459. Epub 2017 Nov 8.

引用本文的文献

1
Bio-reductive Co(iii)-doxorubicin complex for cancer cell-selective delivery of doxorubicin and potent anticancer activity.用于癌细胞选择性递送阿霉素并具有强大抗癌活性的生物还原型钴(III)-阿霉素复合物。
RSC Med Chem. 2025 Aug 7. doi: 10.1039/d5md00360a.
2
Polysaccharide Composites with for Sustained Anti-Inflammatory Skin Therapy.用于持续抗炎皮肤治疗的多糖复合材料。
Polymers (Basel). 2025 Jun 19;17(12):1707. doi: 10.3390/polym17121707.
3
Novel Gels for Post-Piercing Care: Evaluating the Efficacy of Pranoprofen Formulations in Reducing Inflammation.

本文引用的文献

1
Machine Learning-Enabled NIR Spectroscopy in Assessing Powder Blend Uniformity: Clear-Up Disparities and Biases Induced by Physical Artefacts.基于机器学习的近红外光谱法评估粉末混合均匀度:消除物理伪影引起的差异和偏差。
AAPS PharmSciTech. 2022 Oct 13;23(7):277. doi: 10.1208/s12249-022-02403-9.
2
A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles.从表面侵蚀聚合物纳米粒子中释放药物的预测性机械模型。
J Control Release. 2022 Nov;351:883-895. doi: 10.1016/j.jconrel.2022.09.067. Epub 2022 Oct 12.
3
Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products.
用于穿刺后护理的新型凝胶:评估普拉洛芬制剂在减轻炎症方面的疗效。
Gels. 2025 Apr 30;11(5):334. doi: 10.3390/gels11050334.
脂质体作为药用天然产物的多功能纳米载体
Front Chem. 2022 Aug 8;10:963004. doi: 10.3389/fchem.2022.963004. eCollection 2022.
4
Drug release kinetics and biological properties of a novel local drug carrier system.一种新型局部药物载体系统的药物释放动力学及生物学特性
Dent Res J (Isfahan). 2021 Nov 22;18:94. doi: 10.4103/1735-3327.330875. eCollection 2021.
5
Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles.粒径差异大,释放曲线差异小:固体脂质纳米粒的案例研究。
Pharm Dev Technol. 2021 Dec;26(10):1110-1119. doi: 10.1080/10837450.2021.1998114. Epub 2021 Nov 7.
6
Design of PLGA-Based Drug Delivery Systems Using a Physically-Based Sustained Release Model.基于物理持续释放模型的 PLGA 药物输送系统设计。
J Pharm Sci. 2022 Feb;111(2):345-357. doi: 10.1016/j.xphs.2021.09.007. Epub 2021 Sep 11.
7
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant.吗替麦考酚酯固体脂质纳米粒:控制免疫抑制剂释放的尝试。
Int J Nanomedicine. 2020 Aug 5;15:5603-5612. doi: 10.2147/IJN.S255636. eCollection 2020.
8
A novel kinetic model to describe the ultra-fast triggered release of thermosensitive liposomal drug delivery systems.一种描述热敏脂质体药物递送系统超快速触发释放的新型动力学模型。
J Control Release. 2020 Aug 10;324:669-678. doi: 10.1016/j.jconrel.2020.05.047. Epub 2020 Jun 6.
9
Dual Release Model to Evaluate Dissolution Profiles from Swellable Drug Polyelectrolyte Matrices.双层释放模型评价可溶胀药物聚电解质基质的溶出度。
Curr Drug Deliv. 2020;17(6):511-522. doi: 10.2174/1567201817666200512093115.
10
A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles.基于聚乳酸-羟基乙酸共聚物(PLGA)的纳米颗粒药物释放动力学分析模型的比较
Heliyon. 2020 Feb 28;6(2):e03451. doi: 10.1016/j.heliyon.2020.e03451. eCollection 2020 Feb.